Product
VEDOLIZUMAB
1 clinical trial
1 indication
Indication
ULCERATIVE COLITISClinical trial
Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)Status: Terminated, Estimated PCD: 2020-01-01